ECOG-ACRIN EAY131-X

Primary Category:

Treatment Protocols

Disease Category:

Molecular Profiling

Status:

Closed

MATCH Treatment Subprotocol X: EAY131-X: Phase II Study of DasatinibĀ in Patients with Tumors with DDR2 Mutations

(See required screening study ECOG-ACRIN EAY131)

Effective immediately, 06/15/18, EAY131-X is formally closed to accrual, as the prevalence rate for the mutation remains at zero.

NCT#02465060